Follow Up Export | International VRL Registry Project

Doctor Identification Code	Patient Identification	Reporting Interval Year/Quarter	Reporting Interval Evaluation	RIGHT Eye Involvement	Right Eye Foot	Right Eye Metre	Right Eye Decimal	Right Eye LogMAR	Right Ocular involvement during reporting interval	Right Eye Other Tissue Input	Right Eye Vitrectomy during reporting interval	Right Eye Intravitreal methotrexate	Right Eye Number of MTX Injections	Right Eye MTX Unit Dose [mg/0.1mL]	Right Eye Intravitreal rituximab	Right Eye Number of RITUX Injections	Right Eye RITUX Unit Dose [mg/0.1mL]	Right Eye Intravitreal melphalan	Right Eye Number of melphalan injections	Right Eye Unit dose of melphalan [ mg/0.1mL ]	Right Eye Other Intravitreal Drug	Right Eye Other Intravitreal Drug Name	RIGHT Eye Number of Other Intravitreal Drug Injections	Right Eye Unit dose of Other Intravitreal Drug	Right Eye other Intravitreal Drug Units (e.g. mg/mL)	Right Eye Ocular Irradiation	Right Eye Total dose [ Gy ]	Right Eye Focal ocular treatment during reporting interval	Right Eye Complications during reporting interval	Right Eye Other complication OR ocular surgery	Right Eye status at end of reporting interval	Right Eye Status Define This	LEFT Eye Involvement	Left Eye Foot	Left Eye Metre	Left Eye Decimal	Left Eye LogMAR	Left Ocular involvement during reporting interval	Left Eye Other Tissue Input	Left Eye Vitrectomy during reporting interval	Left Eye Intravitreal methotrexate	Left Eye Number of MTX Injections	Left Eye MTX Unit Dose [mg/0.1mL]	Left Eye Intravitreal rituximab	Left Eye Number of RITUX Injections	Left Eye RITUX Unit Dose [mg/0.1mL]	Left Eye Intravitreal melphalan	Left Eye Number of melphalan injections	Left Eye Unit dose of melphalan [ mg/0.1mL ]	Left Eye Other Intravitreal Drug	Left Eye Other Intravitreal Drug Name	Left Eye Number of Other Intravitreal Drug injections	Left Eye Unit dose of Other Intravitreal drug	Left Eye Other Intravitreal Drug Units (e.g. mg/mL)	Left Eye Ocular Irradiation	Left Eye Total dose [ Gy ]	Left Eye Focal ocular treatment during reporting interval	Left Eye Complications during reporting interval	Left Eye Other complication OR ocular surgery	Left Eye status at end of reporting interval	Left Eye Status Define This	Extra-ocular involvement at any time during reporting interval	Extra-ocular involvement Other Input	Extra-ocular treatment during reporting interval	Extra-ocular Treatment Other Input	Complications of extra-ocular treatment during reporting interval	Extra-ocular Treatment Complications Other Input	Years	Months	Patient Status at End of Reporting Interval	Cause of death	Revised non-lymphoma diagnosis input	Comments	Progress
Doctor Identification Code	Patient Identification	Reporting Interval Year/Quarter	Reporting Interval Evaluation	RIGHT Eye Involvement	Right Eye Foot	Right Eye Metre	Right Eye Decimal	Right Eye LogMAR	Right Ocular involvement during reporting interval	Right Eye Other Tissue Input	Right Eye Vitrectomy during reporting interval	Right Eye Intravitreal methotrexate	Right Eye Number of MTX Injections	Right Eye MTX Unit Dose [mg/0.1mL]	Right Eye Intravitreal rituximab	Right Eye Number of RITUX Injections	Right Eye RITUX Unit Dose [mg/0.1mL]	Right Eye Intravitreal melphalan	Right Eye Number of melphalan injections	Right Eye Unit dose of melphalan [ mg/0.1mL ]	Right Eye Other Intravitreal Drug	Right Eye Other Intravitreal Drug Name	RIGHT Eye Number of Other Intravitreal Drug Injections	Right Eye Unit dose of Other Intravitreal Drug	Right Eye other Intravitreal Drug Units (e.g. mg/mL)	Right Eye Ocular Irradiation	Right Eye Total dose [ Gy ]	Right Eye Focal ocular treatment during reporting interval	Right Eye Complications during reporting interval	Right Eye Other complication OR ocular surgery	Right Eye status at end of reporting interval	Right Eye Status Define This	LEFT Eye Involvement	Left Eye Foot	Left Eye Metre	Left Eye Decimal	Left Eye LogMAR	Left Ocular involvement during reporting interval	Left Eye Other Tissue Input	Left Eye Vitrectomy during reporting interval	Left Eye Intravitreal methotrexate	Left Eye Number of MTX Injections	Left Eye MTX Unit Dose [mg/0.1mL]	Left Eye Intravitreal rituximab	Left Eye Number of RITUX Injections	Left Eye RITUX Unit Dose [mg/0.1mL]	Left Eye Intravitreal melphalan	Left Eye Number of melphalan injections	Left Eye Unit dose of melphalan [ mg/0.1mL ]	Left Eye Other Intravitreal Drug	Left Eye Other Intravitreal Drug Name	Left Eye Number of Other Intravitreal Drug injections	Left Eye Unit dose of Other Intravitreal drug	Left Eye Other Intravitreal Drug Units (e.g. mg/mL)	Left Eye Ocular Irradiation	Left Eye Total dose [ Gy ]	Left Eye Focal ocular treatment during reporting interval	Left Eye Complications during reporting interval	Left Eye Other complication OR ocular surgery	Left Eye status at end of reporting interval	Left Eye Status Define This	Extra-ocular involvement at any time during reporting interval	Extra-ocular involvement Other Input	Extra-ocular treatment during reporting interval	Extra-ocular Treatment Other Input	Complications of extra-ocular treatment during reporting interval	Extra-ocular Treatment Complications Other Input	Years	Months	Patient Status at End of Reporting Interval	Cause of death	Revised non-lymphoma diagnosis input	Comments	Progress